The New “Opioid Crisis”: Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea

This publication has 30 references indexed in Scilit:

• Incident opioid use is associated with risk of respiratory harm in non-palliative COPD
  European Respiratory Journal, 2017
• Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015
  MMWR. Morbidity and Mortality Weekly Report, 2016
• Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain
  JAMA, 2016
• Association between hypnotics use and increased mortality: causation or confounding?
  European Journal of Clinical Pharmacology, 2015
• Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research
  BMJ, 2013
• Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes
  CMAJ Open, 2013
• Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study
  Journal of Pain and Symptom Management, 2011
• Managing Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice Guideline
  Canadian Respiratory Journal, 2011
• Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea
  BMJ, 2003
• Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD
  Chest, 2002